Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Gland Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:543245NSE Symbol: GLANDP/E(TTM):25.24
ISIN Demat:INE068V01023Div & Yield %:1.02EPS(TTM):70.19
Book Value(Rs):610.0166926Market Cap ( Cr.):29191.54Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 4116.154167.433616.534400.713462.882633.24
Excise Duty0.000.000.000.000.000.00
Net Sales4116.154167.433616.534400.713462.882633.24
Other Income 215.08166.67240.46223.94134.78139.17
Stock Adjustments -130.25-87.4346.92-36.69273.496.90
Total Income4200.984246.673903.914587.963871.152779.31
EXPENDITURE :      
Raw Materials 1600.351732.881732.342072.531765.361108.93
Power & Fuel Cost120.38117.20124.8495.0574.5978.50
Employee Cost 439.02409.95399.70338.57311.36277.66
Other Manufacturing Expenses 188.89186.92153.84137.19130.84102.23
Selling and Administration Expenses 155.54175.97189.65177.43128.4498.54
Miscellaneous Expenses 39.1048.31100.9932.6123.5118.82
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2543.292671.222701.352853.382434.101684.68
Operating Profit1657.701575.441202.551734.581437.041094.63
Interest 22.847.847.415.243.417.18
Gross Profit1634.861567.601195.141729.341433.631087.45
Depreciation169.27162.11146.74110.3098.7894.59
Profit Before Tax1465.591405.491048.401619.041334.85992.86
Tax366.71337.49275.38392.88337.73251.83
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax9.1224.68-2.8014.010.12-31.82
Reported Net Profit1089.751043.33775.831212.16997.01772.86
Extraordinary Items 0.97-0.39-39.553.220.0212.99
Adjusted Net Profit1088.781043.72815.381208.94996.99759.87
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward7054.036010.705234.884022.723025.722252.86
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 329.500.000.000.000.000.00
P & L Balance carried down7814.287054.036010.705234.884022.723025.72
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1800.002000.000.000.000.000.00
Earnings Per Share-Unit Curr66.1463.3447.1173.7860.9549.88
Earnings Per Share(Adj)-Unit Curr66.1463.3447.1173.7860.95NA
Book Value-Unit Curr592.08546.13482.90435.68360.86235.32